BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22075245)

  • 1. Urokinase receptor associates with myocardin to control vascular smooth muscle cells phenotype in vascular disease.
    Kiyan Y; Limbourg A; Kiyan R; Tkachuk S; Limbourg FP; Ovsianikov A; Chichkov BN; Haller H; Dumler I
    Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):110-22. PubMed ID: 22075245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.
    Kiyan J; Smith G; Haller H; Dumler I
    Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4.
    Kiyan Y; Tkachuk S; Hilfiker-Kleiner D; Haller H; Fuhrman B; Dumler I
    J Mol Cell Cardiol; 2014 Jan; 66():72-82. PubMed ID: 24239845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells.
    Kiyan J; Haller H; Dumler I
    Exp Cell Res; 2009 Apr; 315(6):1029-39. PubMed ID: 19133257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase receptor mediates doxorubicin-induced vascular smooth muscle cell senescence via proteasomal degradation of TRF2.
    Hodjat M; Haller H; Dumler I; Kiyan Y
    J Vasc Res; 2013; 50(2):109-23. PubMed ID: 23172421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosuvastatin regulates vascular smooth muscle cell phenotypic modulation in vascular remodeling: role for the urokinase receptor.
    Kiyan J; Kusch A; Tkachuk S; Krämer J; Haller H; Dietz R; Smith G; Dumler I
    Atherosclerosis; 2007 Dec; 195(2):254-61. PubMed ID: 17275828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cell.
    Lugano R; Peña E; Badimon L; Padró T
    J Thromb Haemost; 2012 Oct; 10(10):2158-67. PubMed ID: 22906080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Myb Regulates Proliferation and Differentiation of Adventitial Sca1+ Vascular Smooth Muscle Cell Progenitors by Transactivation of Myocardin.
    Shikatani EA; Chandy M; Besla R; Li CC; Momen A; El-Mounayri O; Robbins CS; Husain M
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1367-76. PubMed ID: 27174098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-3 long-chain polyunsaturated fatty acids inhibit smooth muscle cell migration by modulating urokinase plasminogen activator receptor through MEK/ERK-dependent and -independent mechanisms.
    Whyte C; Thies F; Peyrol L; Balcerzak D
    J Nutr Biochem; 2012 Nov; 23(11):1378-83. PubMed ID: 22221673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid receptor coactivator 3 is a coactivator for myocardin, the regulator of smooth muscle transcription and differentiation.
    Li HJ; Haque Z; Lu Q; Li L; Karas R; Mendelsohn M
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4065-70. PubMed ID: 17360478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta.
    Kiyan J; Kiyan R; Haller H; Dumler I
    EMBO J; 2005 May; 24(10):1787-97. PubMed ID: 15889147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UPA promotes lipid-loaded vascular smooth muscle cell migration through LRP-1.
    Lugano R; Peña E; Casani L; Badimon L; Padró T
    Cardiovasc Res; 2013 Nov; 100(2):262-71. PubMed ID: 23812296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration.
    Zhu Y; Bujo H; Yamazaki H; Ohwaki K; Jiang M; Hirayama S; Kanaki T; Shibasaki M; Takahashi K; Schneider WJ; Saito Y
    Circ Res; 2004 Apr; 94(6):752-8. PubMed ID: 14764453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling.
    Guo X; Shi N; Cui XB; Wang JN; Fukui Y; Chen SY
    Circ Res; 2015 May; 116(10):e71-80. PubMed ID: 25788409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte-expressed urokinase regulates human vascular smooth muscle cell migration in a coculture model.
    Kusch A; Tkachuk S; Lutter S; Haller H; Dietz R; Lipp M; Dumler I
    Biol Chem; 2002 Jan; 383(1):217-21. PubMed ID: 11928816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype.
    van der Veer EP; de Bruin RG; Kraaijeveld AO; de Vries MR; Bot I; Pera T; Segers FM; Trompet S; van Gils JM; Roeten MK; Beckers CM; van Santbrink PJ; Janssen A; van Solingen C; Swildens J; de Boer HC; Peters EA; Bijkerk R; Rousch M; Doop M; Kuiper J; Schalij MJ; van der Wal AC; Richard S; van Berkel TJ; Pickering JG; Hiemstra PS; Goumans MJ; Rabelink TJ; de Vries AA; Quax PH; Jukema JW; Biessen EA; van Zonneveld AJ
    Circ Res; 2013 Oct; 113(9):1065-75. PubMed ID: 23963726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase receptor mediates mobilization, migration, and differentiation of mesenchymal stem cells.
    Vallabhaneni KC; Tkachuk S; Kiyan Y; Shushakova N; Haller H; Dumler I; Eden G
    Cardiovasc Res; 2011 Apr; 90(1):113-21. PubMed ID: 21088115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation.
    Chavakis T; Kanse SM; May AE; Preissner KT
    Biochem Soc Trans; 2002 Apr; 30(2):168-73. PubMed ID: 12023845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells.
    Gupta R; Chetty C; Bhoopathi P; Lakka S; Mohanam S; Rao JS; Dinh DE
    Int J Oncol; 2011 Mar; 38(3):733-44. PubMed ID: 21181094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
    Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.